Molecular Classification Based on the Gene Expression Profiles in Canine Histiocytic Sarcoma Cells
Veterinary and Comparative Oncology · 2025
DOI: 10.1111/vco.13071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary and Comparative Oncology, 2025. Verfasst von Hiroki Sakuma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Veterinary Internal Medicine, Department of Veterinary Medical Sciences, Graduate School of Agricultural and Life Sciences, The Univers…. Hauptthemen laut MEDLINE: Histiocytic Sarcoma, Dog Diseases, Gene Expression Regulation, Neoplastic, Transcriptome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Science and Technology Agency.
Abstract (Originalsprache)
The molecular abnormalities of canine histiocytic sarcoma (CHS) remain to be elucidated. We previously revealed that the sensitivities to dasatinib and trametinib were significantly various among CHS cell lines, indicating the differences in underlying molecular abnormalities. In the present study, we performed RNA sequencing analysis using 11 CHS cell lines to investigate molecular classifications based on the gene expression profiles (GEPs). The clustering analysis showed that CHS cell lines were divided into two distinct clusters. The comparisons of GEPs between the clusters extracted 675 differentially expressed genes (DEGs), and these DEGs were enriched with those related to the regulations of inflammatory responses. Among these DEGs, differences in the expressions of CCL3 , CCL4 , CCL7 , CLEC7A , and TLR4 genes between the two groups were confirmed by RT‐qPCR. Since no significant difference in the activation status of Akt and ERK pathways was observed between the two groups, the NF‐κB pathway was focused on and its activation status was examined in the cell lines. As a result, cell lines belonging to one cluster showed nuclear translocation of the p65 protein together with increased release of CCL5 protein, which is a target molecule of the NF‐κB pathway, in a cell culture supernatant. These results suggested that the molecular pathology of CHS cells might be divided into two categories depending on the activation status of the NF‐κB pathway, and it is necessary to establish precision medicine for each molecular subtype of CHS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Veterinary Internal Medicine, Department of Veterinary Medical Sciences, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
- Veterinary Medical Center, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
- Department of Veterinary Clinical Pathology, Nippon Veterinary and Life Science University, Musashino-shi, Tokyo, Japan.
ORCID-Profile: Hiroki Sakuma, Hirotaka Tomiyasu, Akiyoshi Tani, Makoto Bonkobara, Masaru Okuda
Förderung
- Japan Society for the Promotion of Science
- Japan Science and Technology Agency
Zitieren
APA
Sakuma, H., Tomiyasu, H., Tani, A., Goto-Koshino, Y., Bonkobara, M., & Okuda, M. (2025). Molecular Classification Based on the Gene Expression Profiles in Canine Histiocytic Sarcoma Cells. Veterinary and Comparative Oncology. https://doi.org/10.1111/vco.13071
Vancouver
Sakuma H, Tomiyasu H, Tani A, Goto-Koshino Y, Bonkobara M, Okuda M. Molecular Classification Based on the Gene Expression Profiles in Canine Histiocytic Sarcoma Cells. Veterinary and Comparative Oncology. 2025. doi:10.1111/vco.13071
BibTeX
@article{Sakuma2025,
author = {Sakuma, Hiroki and Tomiyasu, Hirotaka and Tani, Akiyoshi and Goto-Koshino, Yuko and Bonkobara, Makoto and Okuda, Masaru},
title = {Molecular Classification Based on the Gene Expression Profiles in Canine Histiocytic Sarcoma Cells},
journal = {Veterinary and Comparative Oncology},
year = {2025},
doi = {10.1111/vco.13071}
}
EUVIMED